Efficient cellular and humoral immune response and production of virus-neutralizing antibodies by the Hepatitis B Virus S/preS116-42 antigen
Despite the availability of improved antiviral therapies, infection with Hepatitis B virus (HBV) remains a3 significant health issue, as a curable treatment is yet to be discovered. Current HBV vaccines relaying on the efficient expression of the small (S) envelope protein in yeast and the implement...
Main Authors: | Ana-Maria Pantazica, Mihaela-Olivia Dobrica, Catalin Lazar, Cristina Scurtu, Catalin Tucureanu, Iuliana Caras, Irina Ionescu, Adriana Costache, Adrian Onu, Jihong Liu Clarke, Crina Stavaru, Norica Branza-Nichita |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.941243/full |
Similar Items
-
Challenges and Prospects of Plant-Derived Oral Vaccines against Hepatitis B and C Viruses
by: Ana-Maria Madalina Pantazica, et al.
Published: (2021-09-01) -
N-Glycosylation and N-Glycan Processing in HBV Biology and Pathogenesis
by: Mihaela-Olivia Dobrica, et al.
Published: (2020-06-01) -
Activation of ERAD pathway by human hepatitis B virus modulates viral and subviral particle production.
by: Catalin Lazar, et al.
Published: (2012-01-01) -
Modulation of the Unfolded Protein Response by the Human Hepatitis B Virus
by: Norica eBranza-Nichita, et al.
Published: (2014-08-01) -
Generation of a DSF-Guided Refolded Bacterially Expressed Hemagglutinin Ectodomain of Influenza Virus A/Puerto Rico/8/1934 H1N1 as a Model for Influenza Vaccine Antigens
by: Vlad-Constantin Tofan, et al.
Published: (2023-09-01)